Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Retinal Neovascularization

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Retinal Neovascularization in 1 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.

Research Excerpts

ExcerptRelevanceReference
" The effect of the P2 antagonists, suramin and PPADS, on the extent of oxygen-induced retinal neovascularization was analyzed."3.74Involvement of purinergic P2 receptors in experimental retinal neovascularization. ( Croxatto, JO; Gallo, JE; Kvanta, A; Mancini, J; Sarman, S; van der Ploeg, I, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sarman, S1
Mancini, J1
van der Ploeg, I1
Croxatto, JO1
Kvanta, A1
Gallo, JE1

Other Studies

1 other study available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Retinal Neovascularization

ArticleYear
Involvement of purinergic P2 receptors in experimental retinal neovascularization.
    Current eye research, 2008, Volume: 33, Issue:3

    Topics: Animals; Animals, Newborn; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Mice; M

2008